Leveraging Old Hepatitis C Therapies | NEJM
Older drugs could potentially advance U.S. hepatitis C elimination efforts. The government could act like a business and use all current and historical market information to its advantage.
Older drugs could potentially advance U.S. hepatitis C elimination efforts. The government could act like a business and use all current and historical market information to its advantage.
A 64-year-old woman presented with a 5-month history of fatigue and a 2-week history of fever and cough, with lymphadenopathy and splenomegaly. A serum sample…
European Respiratory Society. 36,100 likes · 141 talking about this. With members in over 100 countries, the European Respiratory Society (ERS) aims to alleviate sufferi
The European Respiratory Journal has issued a call for original research articles, reviews, research letters and viewpoint articles for a series on interstitial lung disease
To take part in this event, you must register in advance. REGISTER NOW (SESSION 2) Register for the full series REGISTER NOW (FULL SERIES) This…
The Academy of paediatric respiratory medicine is intended to provide a comprehensive overview of each of the major fields of paediatric respiratory medicine, based on…
Polymorbidity is an important component of chronic obstructive pulmonary disease (COPD), with cardiovascular diseases being among the most important comorbidities.1 The development of both incident…
Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, within…
An editorial from the International Committee of Medical Journal Editors recommends actions that authors, institutions, funders, journal editors, and publishers can take to protect against…
Background: The incidence of invasive fungal infections is increasing in immune-competent and immune-compromised patients. An examination of the recent literature related to the treatment of…
Rationale: New pulmonary rehabilitation models can improve access to this effective but underused treatment for people with chronic respiratory disease; however, cost-effectiveness has not been…